These findings collectively support the role of the NLRP3inflammasome/IL-1β axis as a pivotal mediator in the pathophysiology ofrecurrent pericarditis, and corroborate the use of targeted therapies to blockthe inflammasome [6]. The gene discussed is IL1B; the disease is pericarditis.